Navigation Links
George Institute receives Gates Foundation grant to survey funding flows
Date:3/20/2008

A team of international health experts is launching a major study to track global funding for research and development (R&D) for neglected diseases in developing countries by surveying global public, private and philanthropic investments. As funding for R&D for neglected diseases has increased, donors do not have a complete overview of how much is currently being spent and on what diseases, which makes determining funding gaps difficult. The George Institute for International Health received a 5 year $US8.8 million grant from the Bill & Melinda Gates Foundation to collect and report global investment into R&D for neglected diseases.

Too often, global health funders must base substantial R&D investment decisions on out-of-date, unreliable information. They lack information about how much or where to invest, or how their investments sit in the context of overall funding flows and priorities, said Dr Mary Moran, Project Leader at the George Institute. By providing an updated and in depth overview, we hope to help donors around the world determine where their investments are most needed, and prevent duplication of effort she added.

Annually for a five year period, The George Institute will survey and analyse public and private global funders, intermediaries and developers, collecting data through an online survey. The survey will examine all aspects of product R&D funding from basic research, through discovery and development, to post-registration activities that support product introduction. It will measure R&D investment into new drugs, vaccines, diagnostics, microbicides and other tools for tropical diseases such as malaria and sleeping sickness, as well as developing-country strains of global diseases such as pneumonia, meningitis and HIV/AIDS, which are often overlooked by product developers that typically prioritize industrialized country markets.

We hope that better information about global funding for R&D for neglected diseases will encourage new investments, and help ensure they are targeted for maximum impact, said Dr. Regina Rabinovich, Director of Infectious Diseases Development at the Gates Foundation.

The project maintains The George Institutes focus on delivering quality public health outcomes. The George Institute for International Health is a multinational not-for-profit research organisation with offices in Australia, China, India and the United Kingdom. The Institute works towards improvement and development of global health through undertaking high quality research, and applying this research to health policy and practice. Given its widely acknowledged work on neglected disease product pipelines and funding, the Health Policy Division of the George Institute is uniquely placed to deliver such an important and vital project.


'/>"/>

Contact: Emma Orpilla
eorpilla@thegeorgeinstitute.org
61-299-934-592
Research Australia
Source:Eurekalert

Related medicine news :

1. Mothers Know Best: NFL Moms Team With Eddie George to Showcase a Better Way to a Healthier Lifestyle
2. Live Webcast With President George H.W. Bush as Bono and DATA Are Honored With National Constitution Centers 2007 Liberty Medal in Historic Philadelphia
3. President George W. Bush Appoints Susan G. Komen for the Cure Founder as Chief of Protocol
4. George Mason University professor receives $2.6 million NIH grant to study Alzheimers disease
5. New USAID grant helps Georgetown meet unmet family planning needs worldwide
6. CNS Response, Inc. Appoints George C. Carpenter IV to Position of President
7. Reunion with patient inspires follow-up study on treatment for DiGeorge syndrome
8. Georgetown leads major effort to combat disparities in DC stroke care
9. Skinvisible Appoints Dr. George Korkos to Its Advisory Board
10. George Harrison Fund for UNICEF Announces Donation for Bangladesh Cyclone Relief
11. DaVita Nurse Gives Keynote Speech to St. Georges Hospital Vascular Access Annual Meeting in London
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating in cancer care, and ... in the eye of the beholder, according to experts who offered insights and commentary ... of Managed Care. For the full issue, click here . , For the ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many women are ... with endometriosis. These women need a treatment plan to not only alleviate symptoms ... can help for preservation of fertility and ultimately achieving a pregnancy. The specialists ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , the largest ... as the Medical Director of its new Mesquite-Samuell Farm facility. , “We are ... Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published ... unfamiliar with. The article goes on to state that individuals are now more comfortable ... less common operations such as calf and cheek reduction. The Los Angeles area medical ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced that ... chosen by their peers for this recognition are considered among the top 2 percent ... special honors as members of this year’s Legal Elite Hall of Fame: Miami ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016  Arkis BioSciences, a leading innovator ... more durable cerebrospinal fluid treatments, today announced it ... funding is led by Innova Memphis, followed by ... private investors.  Arkis, new financing will accelerate the ... market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... "Dialysis Devices Global Market - Forecast to 2022" report ... is the treatment method for the patients with kidney failure, ... and excess fluid from the patient,s blood and thus the ... sodium, potassium and chloride in balance. Increasing ...
(Date:6/23/2016)... 23, 2016 Research and Markets ... Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic ... Coating, Parenteral) - Global Forecast to 2021" report ... The global pharmaceutical excipients market is projected to ... of 6.1% in the forecast period 2016 to 2021. ...
Breaking Medicine Technology: